Letter: Ornithine or citrulline therapy in treatment of Reye's syndrome.

Production of citrulline and ornithine by interferon-gamma treated macrophages.

Arginine and citrulline for the treatment of MELAS syndrome.

Arginine biosynthesis in Neisseria gonorrhoeae: enzymes catalyzing the formation of ornithine and citrulline.

Letter: Thrombolytic therapy in haemolytic-uraemic syndrome.

Effect of ornithine concentration on citrulline synthesis in mouse liver mitochondria.

Letter: Cyclophosphamide in treatment of nephrotic syndrome.

Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome.

Letter: Controlled trial of therapy in Reye's syndrome.

Letter: Complications of ventilator therapy in respiratory distress syndrome.

Letter: Reye's syndrome--virus or artifact in muscle?

Letter: Myasthenic syndrome during treatment with practolol.

Letter: More on alkali therapy of the respiratory distress syndrome.

Low plasma citrulline concentrations during protein restriction in an unaffected infant at risk for ornithine transcarbamylase deficiency.

Letter: Hormonal contraception or therapy and altered immunity.

Letter: Exercise tolerance increased by oxygen therapy or psychologic factors.

Treatment of Subacromial Impingement Syndrome: Platelet-Rich Plasma or Exercise Therapy? A Randomized Controlled Trial.

Letter: Diagnosis and treatment of malignant carcinoid syndrome.

Letter: "Locked-in" syndrome.

Cholestrol emboli syndrome: acute renal insufficiency after a procedure or a thrombolytic therapy or anticoagulant therapy.

Metabolism of citrulline in man.

Monoclonal antibody therapy in the treatment of Reye's syndrome.

Inflammation in irritable bowel syndrome: Myth or new treatment target?

Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment?

Letter: Hypophosphataemia in Reye's syndrome.

Suggest Documents

Production of citrulline and ornithine by interferon-gamma treated macrophages.

Arginine and citrulline for the treatment of MELAS syndrome.

Arginine biosynthesis in Neisseria gonorrhoeae: enzymes catalyzing the formation of ornithine and citrulline.

Letter: Thrombolytic therapy in haemolytic-uraemic syndrome.

Effect of ornithine concentration on citrulline synthesis in mouse liver mitochondria.

Letter: Cyclophosphamide in treatment of nephrotic syndrome.

Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome.

Letter: Controlled trial of therapy in Reye's syndrome.

Letter: Complications of ventilator therapy in respiratory distress syndrome.

Letter: Reye's syndrome--virus or artifact in muscle?

Letter: Myasthenic syndrome during treatment with practolol.

Letter: More on alkali therapy of the respiratory distress syndrome.

Low plasma citrulline concentrations during protein restriction in an unaffected infant at risk for ornithine transcarbamylase deficiency.

Letter: Hormonal contraception or therapy and altered immunity.

Letter: Exercise tolerance increased by oxygen therapy or psychologic factors.

Treatment of Subacromial Impingement Syndrome: Platelet-Rich Plasma or Exercise Therapy? A Randomized Controlled Trial.

Letter: Diagnosis and treatment of malignant carcinoid syndrome.

Letter: "Locked-in" syndrome.

Cholestrol emboli syndrome: acute renal insufficiency after a procedure or a thrombolytic therapy or anticoagulant therapy.

Metabolism of citrulline in man.

Monoclonal antibody therapy in the treatment of Reye's syndrome.

Inflammation in irritable bowel syndrome: Myth or new treatment target?

Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment?

Letter: Hypophosphataemia in Reye's syndrome.

Letter: Ornithine or citrulline therapy in treatment of Reye's syndrome.

Recommend Documents

Follow Us